David Krempa | Chief Business Officer |
Sean Brynjelsen | CEO |
James Gruber | CFO |
Raghuram Selvaraju | H.C. Wainwright |
Good afternoon, and welcome to Eton Pharmaceuticals Second Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please be advised that this call is being recorded at the company's request.
At this time, I would like to turn it over to David Krempa, Chief Business Officer at Eton Pharmaceuticals. Please go ahead.
Thank you, operator.